Alexandre Kaempfen

Dr. Alexandre Kaempfen

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
PSParham Sendi
Parham Sendi
AKAlexandre Kaempfen
Alexandre Kaempfen
IUI. Uçkay
I. Uçkay
RMR. Meier
R. Meier

2 December 2021 in International Journal of Bioprinting
Verified
Journal Article
Open access
PDF file
LWLeonie Waldburger
Leonie Waldburger
RSRomain Schaller
Romain Schaller
CFChristina Furthmüller
Christina Furthmüller
LSLorena Schrepfer
Lorena Schrepfer
DSDirk J. Schaefer
Dirk J. Schaefer
AKAlexandre Kaempfen
Alexandre Kaempfen
In this randomized controlled pilot trial, we compared three-dimensional (3D)-printed made-to-measure splints to conventional custom-made thermoplastic splints. In a clinical setting, we evaluated their general applicability and possible benefits for immobilization in hand surgical patients. We included 20 patients with an indication for immobilization of at least 4 weeks, regardless of the splint design. Patient comfort and satisfaction were assessed with questionnaires at splint fitting, as well as 2 and 4–6 weeks later. The 3D splints were designed and printed in-house with polylactic acid from a 3D surface scan. Our data suggest that 3D-printed splinting is feasible, and patient satisfaction ratings were similar for 3D-printed and thermoplastic splints. The 3D splint production process needs to be optimized and other materials need to be tested before routine implementation is possible or more patients can be enrolled in further studies. Validated quality assessment tools for current splinting are lacking, and further investigation is necessary

Verified
Journal Article
Open access
PDF file
AKAlexandre Kaempfen
Alexandre Kaempfen
ATAtanas Todorov
Atanas Todorov
SGSinan Güven
Sinan Güven
RLRené D. Largo
René D. Largo
Claude JaquiéryClaude Jaquiéry
Claude Jaquiéry
DSDirk J. Schaefer
Dirk J. Schaefer
The gold standard treatment of large segmental bone defects is autologous bone transfer, which suffers from low availability and additional morbidity. Tissue engineered bone able to engraft orthotopically and a suitable animal model for pre-clinical testing are direly needed. This study aimed to evaluate engraftment of tissue-engineered bone with different prevascularization strategies in a novel segmental defect model in the rabbit humerus. Decellularized bone matrix (Tutobone) seeded with bone marrow mesenchymal stromal cells was used directly orthotopically or combined with a vessel and inserted immediately (1-step) or only after six weeks of subcutaneous “incubation” (2-step). After 12 weeks, histological and radiological assessment was performed. Variable callus formation was observed. No bone formation or remodeling of the graft through TRAP positive osteoclasts could be detected. Instead, a variable amount of necrotic tissue formed. Although necrotic area correlated significantly with amount of vessels and the 2-step strategy had significantly more vessels than the 1-step strategy, no significant reduction of necrotic area was found. In conclusion, the animal model developed here represents a highly challenging situation, for which a suitable engineered bone graft with better prevascularization, better resorbability and higher osteogenicity has yet to be developed.

1 November 2017 in Acta Biomaterialia
Verified
Journal Article
Closed access
TITarek Ismail
Tarek Ismail
RORik Osinga
Rik Osinga
ATAtanas Todorov
Atanas Todorov
AHAlexander Haumer
Alexander Haumer
LTLaurent A. Tchang
Laurent A. Tchang
ASArnaud Scherberich
Arnaud Scherberich

22 November 2019 in Journal of Hand and Microsurgery
Verified
Journal Article
Closed access
PDF file
RMRobert Miller
Robert Miller
AKAlexandre Kaempfen
Alexandre Kaempfen
JMJamil Moledina
Jamil Moledina
BSBran Sivakumar
Bran Sivakumar
GSGill Smith
Gill Smith
DNDariush Nikkhah
Dariush Nikkhah
Surgical intervention for thumb duplication can be divided into three categories: simple excision of the accessory thumb, excision of the accessory thumb with reconstruction from available “spare parts,” and combining the two thumbs into one, as described by Bilhaut. This prospectively PROSPERO registered systematic review evaluates the overall, aesthetic and functional outcomes for the latter two options (reconstruction from spare parts vs. combining two thumbs into one), aiming to facilitate evidence-based decision making when addressing thumb duplication and direct future research. The review was performed in accordance with the Cochrane Handbook of Systematic Reviews and PRISMA statement. Embase, PubMed, Medline, and Cochrane databases were systematically searched. Studies offering comparisons of techniques were included. Risk of bias was assessed using the Risk of Bias In Non-randomized Studies—of Intervention tool. The quality of the evidence was assessed using the Grading of Recommendations, Assessment, Development, and Evaluation. Ten retrospective observational studies were included. Data did not consistently allow analysis by procedure type. Four studies reported similar overall outcomes between techniques, while two specifically reported poor overall outcomes for the Bilhaut procedure. Two studies reported comparatively worse aesthetic outcomes for the Bilhaut procedure with four studies reporting comparatively improved functional outcomes for this procedure. Overall, interpretation of outcomes was challenging with no patient-reported outcome measures used. The quality of the evidence was universally “very low” due to all studies being at risk of methodological bias. Based on the available evidence, surgical techniques for thumb duplication correction appear comparable regarding overall outcome. There is limited evidence suggesting reconstruction with spare parts offers superior aesthetic outcomes at the expense of stability. The level of evidence is III. Publication Date: 22 November 2019 (online) © . Thieme Medical and Scientific Publishers Private Ltd. A-12, Second Floor, Sector -2, NOIDA -201301, India

6 December 2021 in Frontiers in Oncology
Verified
Journal Article
Open access
TITarek Ismail
Tarek Ismail
AHAlexander Haumer
Alexander Haumer
ALAlexander Lunger
Alexander Lunger
RORik Osinga
Rik Osinga
AKAlexandre Kaempfen
Alexandre Kaempfen
IMIvan Martin
Ivan Martin
The reconstruction of complex midface defects is a challenging clinical scenario considering the high anatomical, functional, and aesthetic requirements. In this study, we proposed a surgical treatment to achieve improved oral rehabilitation and anatomical and functional reconstruction of a complex defect of the maxilla with a vascularized, engineered composite graft. The patient was a 39-year-old female, postoperative after left hemimaxillectomy for ameloblastic carcinoma in 2010 and tumor-free at the 5-year oncological follow-up. The left hemimaxillary defect was restored in a two-step approach. First, a composite graft was ectopically engineered using autologous stromal vascular fraction (SVF) cells seeded on an allogenic devitalized bone matrix. The resulting construct was further loaded with bone morphogenic protein-2 (BMP-2), wrapped within the latissimus dorsi muscle, and pedicled with an arteriovenous (AV) bundle. Subsequently, the prefabricated graft was orthotopically transferred into the defect site and revascularized through microvascular surgical techniques. The prefabricated graft contained vascularized bone tissue embedded within muscular tissue. Despite unexpected resorption, its orthotopic transfer enabled restoration of the orbital floor, separation of the oral and nasal cavities, and midface symmetry and allowed the patient to return to normal diet as well as to restore normal speech and swallowing function. These results remained stable for the entire follow-up period of 2 years. This clinical case demonstrates the safety and the feasibility of composite graft engineering for the treatment of complex maxillary defects. As compared to the current gold standard of autologous tissue transfer, this patient’s benefits included decreased donor site morbidity and improved oral rehabilitation. Bone resorption of the construct at the ectopic prefabrication site still needs to be further addressed to preserve the designed graft size and shape.